Par Drugs and Chemicals Limited IPO

Par Drugs and Chemicals Limited is listed in the SME segment with a price band of ₹51 to ₹51. The figures below are as reported by the exchanges and public sources.

Par Drugs and Chemicals Limited IPO — key facts

• The Par Drugs and Chemicals Limited IPO price band is ₹51 to ₹51 per share.
• As of 5 September 2026, the Par Drugs and Chemicals Limited IPO subscription status is 5.74x overall.
• The issue is open from 03-MAY-2019 to 08-MAY-2019.
• Par Drugs and Chemicals Limited listed on 16-SEP-2021.
• Par Drugs and Chemicals Limited listed at ₹50.45. The listing loss was 1.1% against the upper end of the issue price band.

Par Drugs and Chemicals Limited IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price band

₹51 – ₹51

Issue size

₹8.1 Cr

Fresh issue

₹8.1 Cr

Opens

03-MAY-2019

Closes

08-MAY-2019

Listing

16-SEP-2021

Total subscription

5.74x

Retail

7.97x

NII

3.48x

Lead managers

Pantomath Capital (left lead)

Listing price

₹50.45

Listing day change

-1.1%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.